Table 5 Treatment assessment distribution of the study group
From: PET/CT vs CECT in assessment of therapeutic response in lymphoma
Number | Percent | |
|---|---|---|
CT | ||
Complete regression | 3 | 15.0 |
Progression disease | 2 | 10.0 |
Partial regression | 15 | 75.0 |
Stationary disease | 0 | 0.0 |
PET | ||
Complete regression | 12 | 60.0 |
Progression disease | 2 | 10.0 |
Partial regression | 6 | 30.0 |
Stationary disease | 0 | 0.0 |